Clinical and Translational Discovery (Jun 2022)

Commentary for “antagonizing urotensin receptor is a novel therapeutic strategy for glucocorticoid‐induced skeletal muscle atrophy”

Ashok D. Prabakaran,
Manoj Panta,
Mattia Quattrocelli

Affiliations

Ashok D. Prabakaran: Division of Molecular Cardiovascular Biology The Heart Institute, Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA
Manoj Panta: Division of Molecular Cardiovascular Biology The Heart Institute, Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA
Mattia Quattrocelli: Division of Molecular Cardiovascular Biology The Heart Institute, Cincinnati Children's Hospital Medical Center Cincinnati Ohio USA

DOI: https://doi.org/10.1002/ctd2.91
Journal volume & issue: Vol. 2, no. 2
pp. n/a – n/a

Abstract

No abstracts available.

Published in Clinical and Translational Discovery

ISSN: 2768-0622 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://onlinelibrary.wiley.com/journal/27680622

About the journal